127 related articles for article (PubMed ID: 16988418)
1. Discovery of protein kinase phosphatase inhibitors.
Vogt A; Lazo JS
Methods Mol Biol; 2007; 356():389-400. PubMed ID: 16988418
[TBL] [Abstract][Full Text] [Related]
2. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1.
Vogt A; Tamewitz A; Skoko J; Sikorski RP; Giuliano KA; Lazo JS
J Biol Chem; 2005 May; 280(19):19078-86. PubMed ID: 15753082
[TBL] [Abstract][Full Text] [Related]
3. Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.
Johnston PA; Foster CA; Shun TY; Skoko JJ; Shinde S; Wipf P; Lazo JS
Assay Drug Dev Technol; 2007 Jun; 5(3):319-32. PubMed ID: 17638532
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of a focused library of mitogen-activated protein kinase phosphatase inhibitors.
Arnold DM; Foster C; Huryn DM; Lazo JS; Johnston PA; Wipf P
Chem Biol Drug Des; 2007 Jan; 69(1):23-30. PubMed ID: 17313454
[TBL] [Abstract][Full Text] [Related]
5. Structurally unique inhibitors of human mitogen-activated protein kinase phosphatase-1 identified in a pyrrole carboxamide library.
Lazo JS; Skoko JJ; Werner S; Mitasev B; Bakan A; Koizumi F; Yellow-Duke A; Bahar I; Brummond KM
J Pharmacol Exp Ther; 2007 Sep; 322(3):940-7. PubMed ID: 17538006
[TBL] [Abstract][Full Text] [Related]
6. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.
Kar-Roy A; Korkaya H; Oberoi R; Lal SK; Jameel S
J Biol Chem; 2004 Jul; 279(27):28345-57. PubMed ID: 15096509
[TBL] [Abstract][Full Text] [Related]
8. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
9. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
[TBL] [Abstract][Full Text] [Related]
10. HIV impairs TNF-alpha release in response to Toll-like receptor 4 stimulation in human macrophages in vitro.
Tachado SD; Zhang J; Zhu J; Patel N; Koziel H
Am J Respir Cell Mol Biol; 2005 Dec; 33(6):610-21. PubMed ID: 16109884
[TBL] [Abstract][Full Text] [Related]
11. Hyperosmotic induction of the mitogen-activated protein kinase phosphatase MKP-1 in H4IIE rat hepatoma cells.
Schliess F; Heinrich S; Häussinger D
Arch Biochem Biophys; 1998 Mar; 351(1):35-40. PubMed ID: 9500841
[TBL] [Abstract][Full Text] [Related]
12. Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK.
Liu C; Shi Y; Du Y; Ning X; Liu N; Huang D; Liang J; Xue Y; Fan D
Exp Cell Res; 2005 Oct; 309(2):410-8. PubMed ID: 16081065
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate inhibition of apoptosis requires mitogen-activated protein kinase phosphatase-1 in mouse fibroblast C3H10T 1/2 cells.
Castillo SS; Teegarden D
J Nutr; 2003 Nov; 133(11):3343-9. PubMed ID: 14608042
[TBL] [Abstract][Full Text] [Related]
14. Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatases.
Vogt A; Lazo JS
Methods; 2007 Jul; 42(3):268-77. PubMed ID: 17532514
[TBL] [Abstract][Full Text] [Related]
15. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
16. Adrenocorticotropin induces mitogen-activated protein kinase phosphatase 1 in Y1 mouse adrenocortical tumor cells.
Bey P; Gorostizaga AB; Maloberti PM; Lozano RC; Poderoso C; Cornejo Maciel F; Podestá EJ; Paz C
Endocrinology; 2003 Apr; 144(4):1399-406. PubMed ID: 12639923
[TBL] [Abstract][Full Text] [Related]
17. Insulin regulates MAP kinase phosphatase-1 induction in Hirc B cells via activation of both extracellular signal-regulated kinase (ERK) and c-Jun-N-terminal kinase (JNK).
Byon JC; Dadke SS; Rulli S; Kusari AB; Kusari J
Mol Cell Biochem; 2001 Feb; 218(1-2):131-8. PubMed ID: 11330828
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
Small GW; Shi YY; Higgins LS; Orlowski RZ
Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
[TBL] [Abstract][Full Text] [Related]
19. Cell-active dual specificity phosphatase inhibitors identified by high-content screening.
Vogt A; Cooley KA; Brisson M; Tarpley MG; Wipf P; Lazo JS
Chem Biol; 2003 Aug; 10(8):733-42. PubMed ID: 12954332
[TBL] [Abstract][Full Text] [Related]
20. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
Seternes OM; Johansen B; Moens U
Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
